Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/08/072208
CTRI/2024/08/072208
Not yet recruiting
未知

To evaluate and compare the safety & efficacy of Skin care formulations in terms of Reduction in Acne and sebum reduction on healthy female subjects - Nil

KOP research centre private limited0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
KOP research centre private limited
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
KOP research centre private limited

Eligibility Criteria

Inclusion Criteria

  • •1\.Indian female subjects.
  • •2\. Healthy Subjects
  • •3\.Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….)
  • •4\.Having oily to mixed oily skin type.
  • •5\.Having mild to moderate acne.

Exclusion Criteria

  • •1\. Being pregnant or breastfeeding or having stopped to breastfeed in the past three months
  • •2\. Having refused to give her/his assent by not signing the consent form
  • •3\. Taking part in another study liable to interfere with this study
  • •4\. Being insulin\-dependent diabetic or non\-insulin\-dependent diabetic with a recent therapy (less than 6 months)
  • •5\. Having a progressive asthma (either under treatment or last fit in the last 2 years)
  • •6\. Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis)
  • •7\. Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)
  • •8\. Being epileptic.
  • •9\. Following a chronic medicinal treatment comprising any of the following products: aspirin\-based products, anti\-inflammatories, anti\-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol)
  • •10\. Having cutaneous hypersensitivity.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Efficacy check of skin care product
CTRI/2023/12/060868SATIYA NUTRACEUTICALS PRIVATE LIMITED
Completed
Phase 3
To evaluate and compare the efficacy and safety of neutral oral cream to heal mucosal wound against placebo on healthy subjects over a 14 day period of home use.
CTRI/2010/091/001242Smilecare Clinic Pvt. Ltd.13, Geetanjali, 234, S. V. Road, Bandra (W), Mumbai- 400 05090
Recruiting
Not Applicable
Comparision of the benefits and harm of indacaterol acetate and glycopyronium bromide with salmetrol and fluticasone in bronchial asthma patients.Health Condition 1: null- Bronchial asthma
CTRI/2018/05/014079Aligarh Muslim University
Completed
Phase 2
Comparative study of Silver sulfadiazine cream (nanonized)and Silverex cream in burns wounds
CTRI/2011/09/002030Ranbaxy Laboratories Ltd36
Completed
Phase 3
anonized Silver Sulfadiazine Cream in prevention of Infections in Burn woundsHealth Condition 1: null- Prophylaxis of Infection in Burn Wounds
CTRI/2014/11/005188Sun Pharmaceutical Industries Limited250